Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Membr Transp Signal

Internalization of serotonin 5‐HT 1A autoreceptors as an imaging biomarker of antidepressant response

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Serotonin (5‐hydroxytryptamine, 5‐HT) and its various receptors are involved in numerous CNS functions. Among the currently known 5‐HT receptors, the 5‐HT1A receptor is the best characterized subtype. It is tightly implicated in the pathogenesis of mood disorders, notably in depression, and thus represents an important target for drug therapy. Binding to 5‐HT1A receptors can be visualized and quantified by positron emission tomography (PET), facilitating the translation from animal research to man. Using the 5‐HT1A radiotracer [18F]MPPF, recent PET studies in cat and human have provided evidence that internalization of 5‐HT1A autoreceptors is amenable to in vivo neuroimaging at the very onset of specific serotonin reuptake inhibitor (SSRI) administration. The in vivo detection of this phenomenon in human is promising in terms of clinical management, particularly as an early biomarker of responsiveness to SSRI treatment. However, several questions are still pending regarding the correlation between 5‐HT1A internalization at the onset of the treatment and the ensuing therapeutic efficacy. WIREs Membr Transp Signal 2012,1:239–245. doi: 10.1002/wmts.11

Figure 1.

Immunocytochemical and brain imaging of 5‐HT1A autoreceptor internalization. (a) Schematic representation of [18F]MPPF binding to 5‐HT1A autoreceptors in 5‐HT neurons. Under basal conditions (upper image), 5‐HT1A autoreceptors are mostly located on the somatodendritic plasma membrane of 5‐HT neurons and available for [18F]MPPF binding (blue shapes). After indirect activation of 5‐HT1A autoreceptors by acute administration of fluoxetine (which increases the extracellular concentration of 5‐HT), 5‐HT1A receptors are internalized in the cytoplasm (lower image) and no longer available for [18F]MPPF binding in vivo. (b) Electron micrographs illustrating the subcellular localization of 5‐HT1A receptors in DRN dendrites, as revealed by immuno‐electron microscopy (immunogold labeling). In a control rat (upper image), the immunogold particles are mostly found on the plasma membrane, whereas 1 h after fluoxetine administration (10 mg/kg i.p.), there is a 30–40% reduction in the density of this plasmalemmal labeling and a corresponding increase in the cytoplasmic labeling (lower image). (Reprinted with permission from Ref 26. Copyright 2004 Elsevier) (c) Color‐coded PET images of a cat brain showing the summed distribution of [18F]MPPF, before (upper image) and 1 h after (lower image) the acute administration of fluoxetine (10 mg/kg i.p.). White arrowheads point at the DRN, in which a selective decrease in [18F]MPPF binding is observed after the treatment. (Reprinted with permission from Ref 32. Copyright 2006 Elsevier) (d) Color‐coded PET images of the summed distribution of [18F]MPPF in the brain of eight subjects who received placebo (upper image) or a unique oral dose of fluoxetine (20 mg), 5 h before the scan (lower image). White arrowheads point at the DRN, in which [18F]MPPF binding is selectively decreased after fluoxetine. Empty arrowheads point at the hippocampus in which [18F]MPPF binding is unchanged. (Reprinted with permission from Ref 33. Copyright 2008 Elsevier)

[ Normal View 57K | Magnified View 92K ]

Browse by Topic

Introduction to Membrane Signaling Systems > Techniques
Ligand-gated Ion Channels and Receptors > Serotonergic Receptors
blog comments powered by Disqus

Access to this WIREs title is FREE for members of registered institutions.

Register Your Institution Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts